Agio Pharmaceuticals Limited Praziquantel Export Data — India (DGFT 2022–2026)

Name: Agio Pharmaceuticals Limited Praziquantel Export Records India — #8 Exporter, 9 Shipments, $72.5K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Praziquantel

India Pharmaceutical Trade Intelligence

$2.9M148 Suppliers80 CountriesHS 30049099

ExportsIndia → PHILIPPINES32.0%India → MOZAMBIQUE7.4%

ImportsFRANCE → India$32.9M GERMANY → India$1.7M

#1 Supplier: LOB INTERNATIONAL

Agio Pharmaceuticals Limited — Praziquantel Exporter #8 | $72.5K Trade Value | TransData Nexus | TransData Nexus

Agio Pharmaceuticals Limited — Praziquantel Exporter Profile

Indian Pharmaceutical Exporter · #8 for Praziquantel · $72.5K export value · DGFT Verified

Agio Pharmaceuticals Limited is the #8 Indian exporter of Praziquantel with $72.5K in export value and 9 verified shipments. Agio Pharmaceuticals Limited holds a 2.5% market share in Praziquantel exports across 2 countries. The company exports 15 pharmaceutical products worth $11.9M across 8 therapeutic categories.

Agio Pharmaceuticals Limited — Praziquantel Export Profile: Buyers & Destinations

Agio Pharmaceuticals Limited Praziquantel export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Praziquantel?

Country	Value	Shipments	Share
PHILIPPINES	$550.0K	11	27.6%
MOZAMBIQUE	$215.7K	33	10.8%
NIGERIA	$203.8K	12	10.2%
UNITED STATES	$199.8K	10

Who Are the Top Buyers of Praziquantel from India?

Buyer	Country	Value	Orders
KHRIZ PHARMA TRADING INC	PHILIPPINES	$350.0K	7
WHO CAMEROON	CAMEROON	$129.6K	3
M/S,GREAT TIMEC PHARMA CO, LTD,	NIGERIA	$110.2K	4
ENDURE MEDICAL, INC.	PHILIPPINES	$100.0K	2
SEPROS LIMITED	KENYA	$69.2K	12
AFRI FARMACIA LDA	MOZAMBIQUE	$59.1K	6
NEGADRAS GENERAL TRADING COMPANY PL	ETHIOPIA	$53.5K	3
MEDECINS SANS FRONTIERES LOGISTIQUE	FRANCE	$44.6K	2
AFRI PHARMACIA LDA	MOZAMBIQUE	$41.8K	2
ZINOM INTERNACIONAL LDA	ANGOLA	$40.2K	2

India's Praziquantel is purchased by 200 buyers worldwide. The top buyer is KHRIZ PHARMA TRADING INC (PHILIPPINES), followed by WHO CAMEROON and M/S,GREAT TIMEC PHARMA CO, LTD,.

How Does Agio Pharmaceuticals Limited Compare to Nearest Praziquantel Exporters?

Exporters ranked immediately above and below #8 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	MEDOPHARM	$97.8K	6	5	$16.3K
7	BHARAT PARENTERALS LIMITED	$74.4K	20	1	$3.7K
8	AGIO PHARMACEUTICALS LIMITED ★	$72.5K	9	2	$8.1K
9	ZENEX ANIMAL HEALTH INDIA PRIVATE LIMITED	$71.4K	14	2	$5.1K
10	CIARA PHARMACEUTICALS	$59.1K	6	1	$9.9K

Agio Pharmaceuticals Limited ranks #8 among 148 Indian Praziquantel exporters. Average shipment value of $8.1K compared to the market average of $9.5K. The closest competitors by value are MEDOPHARM and BHARAT PARENTERALS LIMITED.

Which Indian Ports Ship Praziquantel Exports?

Port	Shipments	% Share
SAHAR AIR	164	28.1%
SAHAR AIR CARGO ACC (INBOM4)	97	16.6%
Bombay Air	41	7.0%
NHAVA SHEVA SEA (INNSA1)	34	5.8%
Bombay Air Cargo	30	5.1%
JNPT/ NHAVA SHEVA SEA	20	3.4%
DELHI AIR	19	3.3%
DELHI AIR CARGO ACC (INDEL4)	18	3.1%

Geopolitical & Trade Policy Impact on Agio Pharmaceuticals Limited's Praziquantel Exports

Recent geopolitical developments have introduced complexities into the pharmaceutical export landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential losses for Indian exporters. According to Pharmaceutical Commerce, maritime carriers' booking suspensions and diversions around the Cape of Good Hope are elongating lead times and pressurizing Suez-linked lanes, disproportionately impacting time-sensitive pharmaceutical replenishment cycles. This situation poses challenges for Agio Pharmaceuticals, particularly in maintaining timely deliveries to key markets.

In the United States, recent tariff implementations have affected a significant portion of Indian exports. The Federation of Indian Export Organisations highlighted that the latest U.S. tariffs impact nearly 55% of India's outbound shipments to America, placing Indian exporters at a competitive disadvantage. For Agio, which relies on the U.S. market, these tariffs could necessitate strategic adjustments to pricing and supply chain logistics.

The European Union's stringent regulatory changes, including the Falsified Medicines Directive, demand enhanced compliance measures from exporters. Agio's ability to adapt to these evolving standards will be crucial in sustaining its market presence in the EU.

Agio Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA increasing inspections of manufacturing facilities. India, hosting over 600 US FDA-approved sites, faces challenges in maintaining compliance. The US FDA conducted more than 200 inspections in 2023, with plans to increase this number in 2024. For Agio Pharmaceuticals, ensuring adherence to Good Manufacturing Practices (GMP) and other quality standards is imperative to avoid potential export bans or reputational damage.

Additionally, the prevalence of counterfeit drugs has raised concerns about India's reputation as a reliable supplier. Agio must implement robust quality control systems and transparent governance to navigate this landscape effectively.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Praziquantel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Agio Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 80+ countries, 200+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Praziquantel

Praziquantel

Agio Pharmaceuticals Limited — Praziquantel Exporter Profile

Agio Pharmaceuticals Limited — Praziquantel Export Profile: Buyers & Destinations

Where Does India Export Praziquantel?

Who Are the Top Buyers of Praziquantel from India?

What Is India's Total Praziquantel Export Value and How Much Does Agio Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Agio Pharmaceuticals Limited's Praziquantel Exports?

How Does Agio Pharmaceuticals Limited Compare to Other Indian Praziquantel Exporters?

Regulatory Requirements: Exporting Praziquantel to Key Markets

Nigeria — NAFDAC

United States — FDA

How Does Agio Pharmaceuticals Limited Compare to Nearest Praziquantel Exporters?

Which Indian Ports Ship Praziquantel Exports?

What Other Antimalarial & Antiparasitic Products Does Agio Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Agio Pharmaceuticals Limited's Praziquantel Exports

Agio Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Agio Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Praziquantel Export Data from Agio Pharmaceuticals Limited

Praziquantel Stats

Company Overview

Top Products by Agio Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source